Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...

The blood–brain barrier is the biggest challenge to the development of drugs that target the CNS. Most capillary beds leak plasma contents between and across endothelial cells by way of window-like ...

The blood–brain barrier (BBB ... enable controlled and targeted drug delivery without damaging the BBB. Several nanoparticles (NPs) have been used for crossing the BBB. Among these, polymeric ...

The 3 rd Annual Blood-Brain Barrier Summit is dedicated to helping drug developers enhance drug delivery across the Blood-Brain Barrier (BBB) to enable effective treatments for neurodegenerative ...

New research from Emory University and international organizations could be a breakthrough in treating childhood brain cancer ...

The blood-brain barrier (BBB) is located at the interface between the vascular system and the ... Exogenous compounds that can induce BBB dysfunction include those administered to enhance drug ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

In his work with NeOnc Technologies, Dr. Chen is developing a new delivery system which is designed to help cancer drugs cross the blood-brain barrier. Historically, medical therapy for ...